Celularity News

News

Ticker

CELU

ISIN

US1511902041

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Celularity Eulerpool News

Celularity Stock News

Celularity is being monitored by journalists and investors worldwide. We gather the latest Celularity news here.

February 10·
Benzinga
Celularity Receives $12.2M In Net Cash Proceeds From Sale Of ~$126.3M Of Unused New Jersey NOLs And $1.9M Of Unused New Jersey R&D Tax Credits
December 26·
Benzinga
Celularity CEO Comments After CMS Withdraws Skin Substitute LCDs Effective Immediately Ahead Of Jan. 1, 2026 Start Date While Flat $127.28 Per Sq Cm Payment Rate Remains For 2026
October 14·
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 9·
Benzinga
WBB Securities Upgrades Celularity to Buy, Maintains Price Target to $6
September 3·
Yahoo
Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance
September 2·
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 16·
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 1·
Yahoo
Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies
June 2·
Yahoo
Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology
May 9·
Yahoo
Celularity Announces Full Year 2024 Operating and Financial Results
April 25·
Yahoo
Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees
April 14·
Benzinga
Celularity Says Welcomes Action By CMS to Revise To Jan. 1, 2026 The Effective Date Of Medicare Local Coverage Determination Titled 'Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers'
February 25·
Yahoo
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products
February 24·
Benzinga
Celularity Announces Master Services Collaboration With BlueSphere Bio For Manufacturing BSB Cell Therapy Products, Utilizing Florham Park cGMP Facility; Project Involves 37K Sq Ft Space, Focus On TCR T Cell Therapy For AML
December 10·
Yahoo
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
December 6·
Yahoo
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023
November 27·
Yahoo
Celularity Inc. Announces Receipt of Nasdaq Notification
November 20·
Yahoo
Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
November 18·
Yahoo
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
October 23·
Yahoo
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel

Celularity Stock Press Releases

Celularity regularly publishes news on the company's website that are relevant for investors.

Celularity News 2026

This page contains all current news, analysis and press releases for Celularity stock (CELU, ISIN: US1511902041). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Celularity.